SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Marinus Pharmaceuticals, Inc. – ‘10-K’ for 12/31/20 – ‘XML’

On:  Tuesday, 3/9/21, at 5:11pm ET   ·   For:  12/31/20   ·   Accession #:  1558370-21-2646   ·   File #:  1-36576

Previous ‘10-K’:  ‘10-K’ on 3/16/20 for 12/31/19   ·   Next:  ‘10-K’ on 3/24/22 for 12/31/21   ·   Latest:  ‘10-K’ on 3/5/24 for 12/31/23   ·   27 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/09/21  Marinus Pharmaceuticals Inc.      10-K       12/31/20   65:7.6M                                   Toppan Merrill Bridge/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.27M 
 2: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     41K 
 6: EX-10.22    Material Contract                                   HTML     67K 
 3: EX-10.3     Material Contract                                   HTML     78K 
 4: EX-10.4     Material Contract                                   HTML     64K 
 5: EX-10.9     Material Contract                                   HTML     72K 
 7: EX-21       Subsidiaries List                                   HTML     17K 
 8: EX-23.1     Consent of Expert or Counsel                        HTML     21K 
 9: EX-23.2     Consent of Expert or Counsel                        HTML     18K 
10: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
11: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
19: R1          Document and Entity Information                     HTML     82K 
20: R2          Consolidated Balance Sheets                         HTML     89K 
21: R3          Consolidated Balance Sheets (Parenthetical)         HTML     50K 
22: R4          Consolidated Statements of Operations and           HTML     57K 
                Comprehensive Loss                                               
23: R5          Consolidated Statements of Stockholders' Equity     HTML     89K 
24: R6          Consolidated Statements of Stockholders' Equity     HTML     25K 
                (Parenthetical)                                                  
25: R7          Consolidated Statements of Cash Flows               HTML     81K 
26: R8          Organization and Description of the Business        HTML     32K 
27: R9          Summary of Significant Accounting Policies          HTML     66K 
28: R10         Fair Value Measurements                             HTML     65K 
29: R11         Property and Equipment                              HTML     37K 
30: R12         Accrued Expenses                                    HTML     36K 
31: R13         Leases                                              HTML     43K 
32: R14         Investments                                         HTML     20K 
33: R15         Stockholders' Equity                                HTML    146K 
34: R16         Convertible Preferred Stock                         HTML     24K 
35: R17         Commitments and Contingencies                       HTML     26K 
36: R18         Income Taxes                                        HTML     90K 
37: R19         Summary of Significant Accounting Policies          HTML    110K 
                (Policies)                                                       
38: R20         Summary of Significant Accounting Policies          HTML     50K 
                (Tables)                                                         
39: R21         Fair Value Measurements (Tables)                    HTML     61K 
40: R22         Property and Equipment (Tables)                     HTML     36K 
41: R23         Accrued Expenses (Tables)                           HTML     35K 
42: R24         Leases (Tables)                                     HTML     37K 
43: R25         Stockholders' Equity (Tables)                       HTML    142K 
44: R26         Income Taxes (Tables)                               HTML     84K 
45: R27         Organization and Description of the Business        HTML     84K 
                (Details)                                                        
46: R28         Summary of Significant Accounting Policies -        HTML     31K 
                Property and Equipment (Details)                                 
47: R29         Summary of Significant Accounting Policies - Loss   HTML     49K 
                Per Share of Common Stock (Details)                              
48: R30         Summary of Significant Accounting Policies -        HTML     20K 
                Segment Information (Details)                                    
49: R31         Fair Value Measurements (Details)                   HTML     33K 
50: R32         Property and Equipment (Details)                    HTML     35K 
51: R33         Accrued Expenses (Details)                          HTML     32K 
52: R34         Leases (Details)                                    HTML     67K 
53: R35         Leases - Maturities (Details)                       HTML     43K 
54: R36         Stockholders' Equity - Incentive Plans (Details)    HTML     38K 
55: R37         Stockholders' Equity - Stock Options and            HTML    161K 
                Restricted Stock (Details)                                       
56: R38         Stockholders' Equity - Equity Distribution          HTML     40K 
                Agreement (Details)                                              
57: R39         Stockholders' Equity - Public Offering (Details)    HTML     38K 
58: R40         Convertible Preferred Stock (Details)               HTML     57K 
59: R41         Commitments and Contingencies - Employee Benefit    HTML     28K 
                Plan and License Agreements (Details)                            
60: R42         Commitments and Contingencies - Employee and        HTML     31K 
                Severance Arrangements (Details)                                 
61: R43         Income Taxes (Details)                              HTML     94K 
63: XML         IDEA XML File -- Filing Summary                      XML    103K 
18: XML         XBRL Instance -- mrns-20201231x10k_htm               XML   1.40M 
62: EXCEL       IDEA Workbook of Financial Reports                  XLSX     73K 
14: EX-101.CAL  XBRL Calculations -- mrns-20201231_cal               XML    138K 
15: EX-101.DEF  XBRL Definitions -- mrns-20201231_def                XML    498K 
16: EX-101.LAB  XBRL Labels -- mrns-20201231_lab                     XML   1.11M 
17: EX-101.PRE  XBRL Presentations -- mrns-20201231_pre              XML    789K 
13: EX-101.SCH  XBRL Schema -- mrns-20201231                         XSD    124K 
64: JSON        XBRL Instance as JSON Data -- MetaLinks              280±   438K 
65: ZIP         XBRL Zipped Folder -- 0001558370-21-002646-xbrl      Zip    406K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.20.4 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 147 </ContextCount>
<ElementCount> 348 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 47 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 5 </UnitCount>
<MyReports>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00090 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00100 - Statement - CONSOLIDATED BALANCE SHEETS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/StatementConsolidatedBalanceSheets </Role>
<ShortName> CONSOLIDATED BALANCE SHEETS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/StatementConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> CONSOLIDATED BALANCE SHEETS (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss </Role>
<ShortName> CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00300 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/StatementConsolidatedStatementsOfStockholdersEquity </Role>
<ShortName> CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00305 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical </Role>
<ShortName> CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/StatementConsolidatedStatementsOfCashFlows </Role>
<ShortName> CONSOLIDATED STATEMENTS OF CASH FLOWS </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 10101 - Disclosure - Organization and Description of the Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureOrganizationAndDescriptionOfBusiness </Role>
<ShortName> Organization and Description of the Business </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 10201 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 10301 - Disclosure - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureFairValueMeasurements </Role>
<ShortName> Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 10401 - Disclosure - Property and Equipment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosurePropertyAndEquipment </Role>
<ShortName> Property and Equipment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 10501 - Disclosure - Accrued Expenses </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureAccruedExpenses </Role>
<ShortName> Accrued Expenses </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 10601 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureLeases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 10701 - Disclosure - Investments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureInvestments </Role>
<ShortName> Investments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 10801 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureStockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 10901 - Disclosure - Convertible Preferred Stock </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureConvertiblePreferredStock </Role>
<ShortName> Convertible Preferred Stock </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 11001 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureCommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 11101 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureIncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables </Role>
<ShortName> Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 30303 - Disclosure - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureFairValueMeasurementsTables </Role>
<ShortName> Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureFairValueMeasurements </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 30403 - Disclosure - Property and Equipment (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosurePropertyAndEquipmentTables </Role>
<ShortName> Property and Equipment (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosurePropertyAndEquipment </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 30503 - Disclosure - Accrued Expenses (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureAccruedExpensesTables </Role>
<ShortName> Accrued Expenses (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureAccruedExpenses </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 30603 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureLeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureLeases </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 30803 - Disclosure - Stockholders' Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureStockholdersEquityTables </Role>
<ShortName> Stockholders' Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureStockholdersEquity </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 31103 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureIncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureIncomeTaxes </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 40101 - Disclosure - Organization and Description of the Business (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails </Role>
<ShortName> Organization and Description of the Business (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureOrganizationAndDescriptionOfBusiness </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 40201 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Property and Equipment (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 40202 - Disclosure - Summary of Significant Accounting Policies - Loss Per Share of Common Stock (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesLossPerShareOfCommonStockDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Loss Per Share of Common Stock (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 40203 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentInformationDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Segment Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 40301 - Disclosure - Fair Value Measurements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureFairValueMeasurementsDetails </Role>
<ShortName> Fair Value Measurements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 40401 - Disclosure - Property and Equipment (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosurePropertyAndEquipmentDetails </Role>
<ShortName> Property and Equipment (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosurePropertyAndEquipmentTables </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 40501 - Disclosure - Accrued Expenses (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureAccruedExpensesDetails </Role>
<ShortName> Accrued Expenses (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureAccruedExpensesTables </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 40601 - Disclosure - Leases (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureLeasesDetails </Role>
<ShortName> Leases (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureLeasesTables </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 40602 - Disclosure - Leases - Maturities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureLeasesMaturitiesDetails </Role>
<ShortName> Leases - Maturities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 35 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 40801 - Disclosure - Stockholders' Equity - Incentive Plans (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureStockholdersEquityIncentivePlansDetails </Role>
<ShortName> Stockholders' Equity - Incentive Plans (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 36 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 40802 - Disclosure - Stockholders' Equity - Stock Options and Restricted Stock (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureStockholdersEquityStockOptionsAndRestrictedStockDetails </Role>
<ShortName> Stockholders' Equity - Stock Options and Restricted Stock (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 40803 - Disclosure - Stockholders' Equity - Equity Distribution Agreement (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureStockholdersEquityEquityDistributionAgreementDetails </Role>
<ShortName> Stockholders' Equity - Equity Distribution Agreement (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 40804 - Disclosure - Stockholders' Equity - Public Offering (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureStockholdersEquityPublicOfferingDetails </Role>
<ShortName> Stockholders' Equity - Public Offering (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 39 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 40901 - Disclosure - Convertible Preferred Stock (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureConvertiblePreferredStockDetails </Role>
<ShortName> Convertible Preferred Stock (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureConvertiblePreferredStock </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 41001 - Disclosure - Commitments and Contingencies - Employee Benefit Plan and License Agreements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureCommitmentsAndContingenciesEmployeeBenefitPlanAndLicenseAgreementsDetails </Role>
<ShortName> Commitments and Contingencies - Employee Benefit Plan and License Agreements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 41 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 41002 - Disclosure - Commitments and Contingencies - Employee and Severance Arrangements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureCommitmentsAndContingenciesEmployeeAndSeveranceArrangementsDetails </Role>
<ShortName> Commitments and Contingencies - Employee and Severance Arrangements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="mrns-20201231x10k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 41101 - Disclosure - Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.marinuspharma.com/role/DisclosureIncomeTaxesDetails </Role>
<ShortName> Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.marinuspharma.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 43 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-K" original="mrns-20201231x10k.htm"> mrns-20201231x10k.htm </File>
<File> mrns-20201231.xsd </File>
<File> mrns-20201231_cal.xml </File>
<File> mrns-20201231_def.xml </File>
<File> mrns-20201231_lab.xml </File>
<File> mrns-20201231_pre.xml </File>
<File> mrns-20201231xex10d22.htm </File>
<File> mrns-20201231xex10d3.htm </File>
<File> mrns-20201231xex10d4.htm </File>
<File> mrns-20201231xex10d9.htm </File>
<File> mrns-20201231xex21.htm </File>
<File> mrns-20201231xex23d1.htm </File>
<File> mrns-20201231xex23d2.htm </File>
<File> mrns-20201231xex31d1.htm </File>
<File> mrns-20201231xex31d2.htm </File>
<File> mrns-20201231xex32d1.htm </File>
<File> mrns-20201231xex4d3.htm </File>
</InputFiles>
<SupplementalFiles>
<File> mrns-20201231x10k001.jpg </File>
<File> mrns-20201231x10k004.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy> http://fasb.org/srt/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/us-gaap/2020-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2020-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/24  Marinus Pharmaceuticals, Inc.     10-K       12/31/23   79:10M                                    Toppan Merrill Bridge/FA
 3/09/23  Marinus Pharmaceuticals, Inc.     10-K       12/31/22   73:10M                                    Toppan Merrill Bridge/FA
 3/24/22  Marinus Pharmaceuticals, Inc.     10-K       12/31/21   71:8.5M                                   Toppan Merrill Bridge/FA
 8/10/21  Marinus Pharmaceuticals, Inc.     S-8         8/10/21    5:200K                                   Toppan Merrill/FA

23 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/09/20  Marinus Pharmaceuticals, Inc.     8-K:1,9    12/08/20   12:488K                                   Toppan Merrill/FA
11/09/20  Marinus Pharmaceuticals, Inc.     10-Q        9/30/20   44:6.7M                                   Toppan Merrill Bridge/FA
 9/22/20  Marinus Pharmaceuticals, Inc.     8-K:5,8,9   9/22/20   13:244K                                   Toppan Merrill/FA
 7/10/20  Marinus Pharmaceuticals, Inc.     S-8         7/10/20    5:246K                                   Toppan Merrill/FA
 7/09/20  Marinus Pharmaceuticals, Inc.     S-3                    7:1.6M                                   Toppan Merrill/FA
 6/17/20  Marinus Pharmaceuticals, Inc.     8-K:4,9     6/15/20   11:199K                                   Toppan Merrill/FA
 5/29/20  Marinus Pharmaceuticals, Inc.     8-K:1,9     5/28/20   12:454K                                   Toppan Merrill/FA
 5/27/20  Marinus Pharmaceuticals, Inc.     8-K:5,8,9   5/27/20   11:225K                                   Toppan Merrill/FA
 4/02/20  Marinus Pharmaceuticals, Inc.     8-K:5,9     3/31/20   11:209K                                   Toppan Merrill/FA
12/13/19  Marinus Pharmaceuticals, Inc.     8-K:3,5,8,912/11/19   13:403K                                   Toppan Merrill/FA
12/13/19  Marinus Pharmaceuticals, Inc.     8-K:1,3,8,912/10/19   14:731K                                   Toppan Merrill/FA
10/29/19  Marinus Pharmaceuticals, Inc.     8-K:5,9    10/23/19    3:143K                                   Toppan Merrill/FA
 8/08/19  Marinus Pharmaceuticals, Inc.     8-K:2,5,9   8/06/19    3:209K                                   Toppan Merrill/FA
12/07/18  Marinus Pharmaceuticals, Inc.     8-K:1,9    12/07/18    2:199K                                   Toppan Merrill/FA
 8/01/17  Marinus Pharmaceuticals, Inc.     10-Q        6/30/17   41:2.7M                                   Toppan Merrill Bridge/FA
 4/06/17  Marinus Pharmaceuticals, Inc.     8-K:1,9     3/31/17    3:405K                                   Toppan Merrill/FA
11/08/16  Marinus Pharmaceuticals, Inc.     10-Q        9/30/16   42:2.8M                                   Toppan Merrill Bridge/FA
 1/04/16  Marinus Pharmaceuticals, Inc.     8-K:1,9    12/28/15    2:1.1M                                   Toppan Merrill Bridge/FA
 3/12/15  Marinus Pharmaceuticals, Inc.     10-K       12/31/14   66:7.1M                                   Toppan Merrill/FA
 8/07/14  Marinus Pharmaceuticals, Inc.     8-K:1,5,9   8/05/14    3:298K                                   Toppan Merrill/FA
 7/18/14  Marinus Pharmaceuticals, Inc.     S-1/A                  6:2.9M                                   Toppan Merrill-FA
 7/09/14  Marinus Pharmaceuticals, Inc.     S-1/A                  5:3M                                     Toppan Merrill-FA
 5/12/14  Marinus Pharmaceuticals, Inc.     S-1                   17:4.8M                                   Toppan Merrill-FA
↑Top
Filing Submission 0001558370-21-002646   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 8:33:56.2pm ET